IMS Shin-Matsudo Central General Hospital Completes First Patient Treatment with the ZAP-X Gyroscopic Radiosurgery Platform
31 Julio 2024 - 9:07AM
Business Wire
Installation Marks the Third ZAP-X System in
Japan to Offer the Latest Advance in Non-Surgical Brain Tumor
Care
ZAP Surgical Systems, Inc., a leading innovator in the field of
surgical robotics, today announced that IMS Shin-Matsudo Central
General Hospital, located in the heart of Shinmatsudo, Chiba,
Japan, recently completed its inaugural patient treatment utilizing
the cutting-edge ZAP-X® Gyroscopic Radiosurgery® platform.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240731451334/en/
The ZAP-X® Gyroscopic Radiosurgery®
Platform. System image courtesy of Hacettepe University Hospital.
(Photo: Business Wire)
Strategically located approximately 25 miles northeast of Tokyo,
IMS Shin-Matsudo Central General Hospital stands as a center of
medical excellence within the region. As part of the IMS private
hospital group, a network of approximately 140 hospitals, clinics,
and nursing homes, the newly established Shin Matsudo Accuracy
Radiation Therapy (SMART) center is committed to pushing the
boundaries of advanced medical care. Leveraging ZAP-X’s
groundbreaking vault-free capability, the system now resides on the
building’s second floor, and is poised to transform the landscape
of radiosurgery treatments.
Stereotactic radiosurgery (SRS) provides a non-invasive option
for treating many primary and metastatic brain tumors, as well as
other conditions of the head and neck. Notably, SRS has shown
equivalent to superior outcomes compared to traditional open
surgery. Involving only one to five brief outpatient visits, SRS
often allows patients to resume normal activities on the same day
as the procedure.
“The introduction of the ZAP-X platform represents a paradigm
shift in our approach to radiosurgical care,” said Jun Itami, MD,
PhD, Radiation Oncologist, and Director of the SMART Center. "This
installation marks the third ZAP-X platform in Japan, and further
reaffirms our commitment to pioneering medical advancements.”
Central to its innovation, the ZAP-X system unveils a
ground-breaking gyroscopic design capable of guiding radiosurgical
beams from thousands of potential unique angles to an exact focal
point of high-dose radiation delivery to the targeted tumor. This
pioneering approach ideally supports the clinical imperative of
minimizing collateral damage to healthy brain tissue and preserving
patient cognitive function.
ZAP-X also stands out as the first and only vault-free SRS
delivery system, doing away with the necessity for healthcare
providers to construct expensive shielded radiation treatment
rooms. And by employing a contemporary linear accelerator for
radiation generation, ZAP-X is also the first and only dedicated
cranial radiosurgery system that no longer relies on Cobalt-60
radioactive sources, thereby eliminating the substantial expenses
and efforts associated with hosting, securing, and regularly
replacing radioactive isotopes.
About ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X®
Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr.
John R. Adler. In addition to being CEO of ZAP, Dr. Adler is
Emeritus Dorothy & TK Chan Professor of Neurosurgery and
Radiation Oncology at Stanford University. Dr. Adler is also
renowned as the inventor of the CyberKnife® system and founder of
Accuray, Inc. The ZAP-X platform incorporates a unique vault-free
design that typically eliminates the need for costly shielded
treatment rooms. ZAP-X also utilizes a modern linear accelerator to
eliminate legacy use of Cobalt-60. Learn more at ZAP Surgical and
follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240731451334/en/
Mark Arnold, ZAP Surgical Systems, Inc. Senior Vice President,
Marketing +1 650 492 7797, ext. 101 Email: info@zapsurgical.com